Cargando…
高三尖杉酯碱、阿糖胞苷、柔红霉素或去甲氧柔红霉素(HAD/HAI)诱导治疗初治急性髓系白血病的长期疗效分析
OBJECTIVE: To estimate the long-term outcomes and the prognostic factors of homoharringtonine, cytarabine, daunorubicin or idarubicin (HAD/HAI) as induction chemotherapy in de novo acute myeloid leukemia (AML). METHODS: The CR rate, overall survival (OS) rate, relapse free survival (RFS) rate were r...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348197/ https://www.ncbi.nlm.nih.gov/pubmed/27014976 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.02.002 |